Cargando…
Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
Breeding has been used successfully for many years in the fruit industry, giving rise to most of today’s commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286259/ https://www.ncbi.nlm.nih.gov/pubmed/34274949 http://dx.doi.org/10.1038/s41438-021-00601-3 |
_version_ | 1783723709389864960 |
---|---|
author | Lobato-Gómez, Maria Hewitt, Seanna Capell, Teresa Christou, Paul Dhingra, Amit Girón-Calva, Patricia Sarai |
author_facet | Lobato-Gómez, Maria Hewitt, Seanna Capell, Teresa Christou, Paul Dhingra, Amit Girón-Calva, Patricia Sarai |
author_sort | Lobato-Gómez, Maria |
collection | PubMed |
description | Breeding has been used successfully for many years in the fruit industry, giving rise to most of today’s commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction of such novel fruits has been slow and limited with only five genetically engineered fruits currently produced as commercial varieties—virus-resistant papaya and squash were commercialized 25 years ago, whereas insect-resistant eggplant, non-browning apple, and pink-fleshed pineapple have been approved for commercialization within the last 6 years and production continues to increase every year. Advances in molecular genetics, particularly the new wave of genome editing technologies, provide opportunities to develop new fruit cultivars more rapidly. Our review, emphasizes the socioeconomic impact of current commercial fruit cultivars developed by genetic engineering and the potential impact of genome editing on the development of improved cultivars at an accelerated rate. |
format | Online Article Text |
id | pubmed-8286259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82862592021-07-23 Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities Lobato-Gómez, Maria Hewitt, Seanna Capell, Teresa Christou, Paul Dhingra, Amit Girón-Calva, Patricia Sarai Hortic Res Review Article Breeding has been used successfully for many years in the fruit industry, giving rise to most of today’s commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction of such novel fruits has been slow and limited with only five genetically engineered fruits currently produced as commercial varieties—virus-resistant papaya and squash were commercialized 25 years ago, whereas insect-resistant eggplant, non-browning apple, and pink-fleshed pineapple have been approved for commercialization within the last 6 years and production continues to increase every year. Advances in molecular genetics, particularly the new wave of genome editing technologies, provide opportunities to develop new fruit cultivars more rapidly. Our review, emphasizes the socioeconomic impact of current commercial fruit cultivars developed by genetic engineering and the potential impact of genome editing on the development of improved cultivars at an accelerated rate. Nature Publishing Group UK 2021-07-17 /pmc/articles/PMC8286259/ /pubmed/34274949 http://dx.doi.org/10.1038/s41438-021-00601-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Lobato-Gómez, Maria Hewitt, Seanna Capell, Teresa Christou, Paul Dhingra, Amit Girón-Calva, Patricia Sarai Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
title | Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
title_full | Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
title_fullStr | Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
title_full_unstemmed | Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
title_short | Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
title_sort | transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286259/ https://www.ncbi.nlm.nih.gov/pubmed/34274949 http://dx.doi.org/10.1038/s41438-021-00601-3 |
work_keys_str_mv | AT lobatogomezmaria transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities AT hewittseanna transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities AT capellteresa transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities AT christoupaul transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities AT dhingraamit transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities AT gironcalvapatriciasarai transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities |